GlassScriptPhysician profile
Diana Wheeler
NPI 1033813787
$174.56
in general payments reported to CMS, 2019-2025
8 companies · $94.81 in 2025
The $94.81 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $79.75 · 2025: $94.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.57 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.13 | 2024 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.38 | 2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $19.77 | 2024 | Gattex |
| Abbvie INC. | $19.13 | 2025 | |
| United Therapeutics Corporation | $18.51 | 2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $18.47 | 2024 | Airsupra |
| Dexcom, INC. | $16.60 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.